Growth in OS Opportunity lies in expanding the OPRA Implant System adoption beyond current markets by leveraging the recent US digital patient portal launch to increase patient flow and raise awareness among clinicians, distributors, and potential hospital partners.

Regulatory Standout FDA-approved bone-anchored implant system designed for amputees positions Integrum as a differentiated supplier in hospitals and rehab centers; emphasize regulatory track record in conversations with prosthetics clinics and medical device distributors seeking compliant, high-quality solutions.

Strategic Partnerships Strong collaboration with scientists and clinicians for custom-made solutions suggests sales plays around turnkey customization, clinical study partnerships, and center-of-excellence collaborations to expand patient reach and generate case volumes.

Global Expansion New leadership activities in Ukraine and ongoing regional commercial coordination indicate opportunities to partner with regional distributors, to localize training, service, and patient outreach, and to accelerate multi-country deployment.

Brand Positioning Industry sponsorship and active presence at osseointegration events provide a platform to upsell service agreements, remote monitoring, and enhanced support packages for clinics adopting the OPRA system, driving recurring revenue.